CLEOPATRA_3A: CLEOPATRA, figure 3A
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
CLEOPATRA_3A R Documentation
CLEOPATRA, figure 3A
Description
Kaplan-Meier digitized data from CLEOPATRA, figure 3A (PMID 25693012). A reported sample size of 808 for a primary endpoint of PFS in breast cancer.
Usage
CLEOPATRA_3A
Format
A data frame of 808 observations and 3 variables:
time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (control, pertuzumab)
Source
Swain SM, Baselga J, Kim S-B, et al. Pertuzumab, trastuzumab, and
docetaxel in HER2-positive metastatic breast cancer. N Engl J Med
2015; 372: 724–34.
Examples
summary(CLEOPATRA_3A)
kmplot(CLEOPATRA_3A)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| CLEOPATRA_3A | R Documentation |
CLEOPATRA, figure 3A
Description
Kaplan-Meier digitized data from CLEOPATRA, figure 3A (PMID 25693012). A reported sample size of 808 for a primary endpoint of PFS in breast cancer.
Usage
CLEOPATRA_3A
Format
A data frame of 808 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0: no event, 1: event) |
|
arm | treatment arms (control, pertuzumab) | |
Source
Swain SM, Baselga J, Kim S-B, et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med 2015; 372: 724–34.
Examples
summary(CLEOPATRA_3A)
kmplot(CLEOPATRA_3A)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.